Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing proguanil hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Proguanil hydrochloride (substance) |
Inferred relationship |
Some |
|
Proguanil hydrochloride 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Proguanil hydrochloride (substance) |
Inferred relationship |
Some |
|
Atovaquone+proguanil hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Proguanil hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely atovaquone 250 milligram and proguanil 100 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Proguanil hydrochloride (substance) |
Inferred relationship |
Some |
|
Proguanil hydrochloride+chloroquine phosphate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Proguanil hydrochloride (substance) |
Inferred relationship |
Some |
|
Proguanil hydrochloride 100mg tablet and chloroquine phosphate 250mg tablet pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Proguanil hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Proguanil hydrochloride (substance) |
Inferred relationship |
Some |
|
Proguanil hydrochloride 100mg tablet and chloroquine phosphate 250mg tablet pack |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Proguanil hydrochloride (substance) |
Inferred relationship |
Some |
|
Proguanil hydrochloride+chloroquine phosphate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Proguanil hydrochloride (substance) |
Inferred relationship |
Some |
|
Proguanil hydrochloride 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Proguanil hydrochloride (substance) |
Inferred relationship |
Some |
|
Proguanil hydrochloride 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Proguanil hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Proguanil hydrochloride 100 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Proguanil hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Proguanil hydrochloride 100 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Proguanil hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely atovaquone 62.5 milligram and proguanil hydrochloride 25 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Proguanil hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely atovaquone 62.5 milligram and proguanil hydrochloride 25 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Proguanil hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely atovaquone 250 milligram and proguanil hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Proguanil hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely atovaquone 250 milligram and proguanil hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Proguanil hydrochloride (substance) |
Inferred relationship |
Some |
2 |